Results: Overall 549 patients were included in the study; 167 (39%) patients admitted to pediatric wards and 25 (21%) patients admitted to neonatal wards received at least one antimicrobial. Pediatric top three antibiotic groups were third-generation cephalosporins (55 prescriptions, 28%), extended spectrum penicillins (n = 32, 16%) and first-generation cephalosporins (n = 26, 13%). Eleven pediatric patients (85%) received surgical prophylaxis more than 1 day; 143 pediatric patients (86%) received antibiotics intravenously. Lower respiratory tract infections were the most common indications for antibiotic use both in pediatric (n = 60, 35.9%) and neonatal patients (n = 9, 36%). The most used antibiotics for neonatal patients were benzylpenicillin (n = 12, 32%), and gentamicin (n = 9, 24%). Conclusions: We identified a few problematic areas, which need improvement: the high use of third-generation cephalosporins for pediatric patients, prolonged surgical prophylaxis, predominant use of parenteral antibiotics and an urgent need for local antibiotic guidelines.
1.

Introduction
Antibiotics are among the most common medicines given to children [1, 2] . According to some studies, 60% of the children receive at least one antibiotic during their hospital stay [3] . There is been a lot of discussion about the rational use of antibiotics because wrongly used they can become a risk factor for the development of resistant bacteria and extra costs for both hospitals and patients [4] [5] [6] . There are limited reliable data on antibiotic use in neonates and children in hospitals but without such information it is difficult to ''develop strategies for the prevention of infections and the containment of resistant pathogens'' [7] and to improve antibiotic prescribing practices. According to Zarb et al. one of the best ways to monitor antibiotic prescribing would be through monitoring electronic prescribing in hospitals that is still not available in many hospitals in Europe (including Latvian hospitals). The alternative is point prevalence surveys (PPSs) that is also a useful tool for this purpose and allows identifying priorities for quality improvement [8] . There are well-established surveillance methodologies developed by The European Surveillance of Antimicrobial Consumption (ESAC) Project but these PPSs have focused mainly on adults [9] . PPSs have been used in hospitals not only at the European level but also undertaken at the national and individual hospital level [10, 11] . There are some studies on antibiotic use in pediatric population using PPSs [12] but methodology was adopted from adult PPSs and it was not specifically designed for children. This study was a part of the ''Antibiotic Resistance and Prescribing in European Children'' (ARPEC) project. The aim of this particular study was to analyze the use of antibiotics among children at hospitals in Latvia to identify targets for quality improvement.
Materials and methods
A one-day cross-sectional point prevalence survey (PPS) was conducted at those hospitals in Latvia with pediatric and neonatal wards which had agreed to participate in the study. A previously validated and standardized ARPEC methodology was used [13] [14] [15] . Each hospital was registered in the ARPEC database providing the name, geographic location and type of hospital (primary, secondary, tertiary level and specialized hospital and teaching versus nonteaching hospital). Seven major pediatric ward types (general pediatric medicine, four types of specialized pediatric medicine wards, pediatric surgery and pediatric intensive care unit (PICU)) and four major neonatal wards were defined (three levels of neonatal intensive care units (NICUs) and a general neonatal medical ward) [14, 15] For each antimicrobial it was allowed to select only one category. Underlying diagnosis had to be completed in the case of a chronic pre-existing disease. If choices had to be made, those underlying diagnoses related to hospital admission and/ or the antibiotic treatment were taken. Underlying diagnoses groups for pediatric patients were divided into 14 subgroups and it was allowed to select a maximum of three diagnoses out of fourteen categories. For neonatal patients there were also 14 subgroups of underlying diagnoses and it was allowed to select a maximum of three diagnoses out of 14 categories. As denominator data, the number of admitted patients and the number of total available beds in each department was used. Six routes of administration had to be entered: parenteral oral, rectal, inhalation, intramuscular, intrathecal and intraperitoneal. Topical use applied on ''skin'', ''oral'' topical administration (e.g., oral gel) was excluded. Targeted treatment was based upon microbiological culture and/or sensitivity testing, the action of the remedies given are directed against the cause of the disease (e.g., positive blood or sputum culture). Besides data needed for the ARPEC protocol additional information was collected, i.e., whether or not patient received intravenous antibiotics more than 48 h on the day of the PPS and was there a reason for this written down in medical records. After data collection on wards and hospitals, participants sent that information to the local country administrator who used the ARPEC-webPPS program, a web-based application for data-entry and reporting as designed by the Laboratory of Medical Microbiology of the University of Antwerp, Belgium (http://app.esac.ua.ac.be/arpec_webpps/). Online validation procedure was used to validate data entry.
Data entry was validated using the online validation procedure which helped to discover errors or provided warnings (e.g., departments without entered patients' data). Descriptive statistics (SPSS 20) was used to characterize pediatric patients. Ethics approval was obtained from Riga Stradins University Ethics Committee and hospitals were also individually responsible for ascertaining the need for local ethical approval. Overall, in Latvia 10 hospitals participated in this PPS. Three were tertiary-level hospitals, five were regional hospitals, and two were local hospitals. Of them, two were children hospitals and eight adult hospitals with pediatric departments. Nine hospitals surveyed all eligible wards within the hospital; one hospital surveyed only neonatal wards. Two children hospitals accounted for 476 pediatric and neonatal beds (62%). There was observed a wide range of total number of beds: from 10 to 375 (Table 1) . Pediatric surgery wards were in three hospitals, one hospital had pediatric surgical beds within the general medical ward. Five hospitals had one or more NICUs and among them large neonatal units -NICU level three were in three hospitals.
3.
Results Table 2 shows the demographic data of patients under antibiotic treatment and prophylaxis. Lower respiratory tract infections (LRTI) were the most common indications for antibiotic use both in pediatric and neonatal patients (Table 3) . Top three antibiotics for the LRTI treatment in pediatric patients were ceftriaxone (n = 20 prescriptions, 31%), amoxicillin (n = 13, 20%), and clarithromycin (n = 7, 11%). Six pediatric patients had two diagnoses as a reason for antibiotic use. Twelve neonatal patients (48%) and 29 pediatric patients (17%) received more than one antimicrobial. There were one zidovudine and seven fluconazole prescriptions of 243 antimicrobial prescriptions. The rest of prescribed antimicrobials belonged to J01 group antimicrobials. Patients admitted to pediatric wards received 21 different antibiotic (J01 group), and patients admitted to neonatal wards, 13 different antibiotics. Eight antibiotics accounted for 75% of all antibiotic use in pediatric patients and five antibiotics in neonatal patients. Antibiotic classes used for the treatment and prophylaxis of infection are shown in Table 4 . Top five antibiotics for pediatric patients were ceftriaxone (41 prescriptions, 21%), cefazolin (n = 24, 12%), amoxicillin (n = 22, 11%), cefuroxime (n = 18, 9%), and benzylpenicillin (n = 14, 7%). Most used antibiotics for neonatal patients were benzylpenicillin (n = 12, 32%) and gentamicin (n = 9, 24%). In total, there were 15 patients receiving antimicrobial surgical prophylaxis; 13 (87%) received prophylaxis for more than 1 day. The most used antibiotics for surgical pediatric patients were ceftriaxone (n = 7, 26%) and metronidazole (n = 4, 15%), cefazolin (n = 4, 15%), and cefuroxime (n = 4, 15%). In three cases, metronidazole was used in combination with ampicillin, amoxicillin or ceftriaxone, ceftriaxone was also used in combination with oxacillin, cefuroxime was used in combination with gentamicin and benzylpenicillin with clindamycin. In total, 143 (86%) of the pediatric patients received antibiotics intravenously for both treatment and prophylaxis, and 91 (64%) of them, more than 48 h. 
Discussion
This study provides an analysis of antibiotic use in hospitalized pediatric and neonatal patients. The study is important because the use of antibiotics in Latvia according to some studies is the highest among the European countries [16] and it is important to analyze reasons behind such high usage of antibiotics. The study indicates several problematic areas: first of all, the high use of the third-generation cephalosporins in m e d i c i n a 5 0 ( 2 0 1 4 ) 1 7 5 -1 8 1 pediatric population and especially ceftriaxone that was the top one antibiotic used in pediatric patient group. In November 2011 the PPS was done in four hospitals (two of them University hospitals, one regional and one local hospital) and results were almost similar with last November results, i. e., pediatric top three antibiotic groups were penicillins with extended spectrum (n = 39, 40%), the third generation cephalosporins (n = 38, 23%), and combinations of sulfonamides and trimethoprim, incl. derivatives (n = 22, 13%) -the last group was due to a high number of oncohematology patients who received co-trimoxazole for medical prophylaxis. Top three antibiotics for pediatric patients were amoxicillin (n = 23; 14%), co-trimoxazole (n = 22; 13%), and ceftriaxone (n = 21; 13%). In May 2012 the PPS was done in four hospitals (two of them University hospitals, two regional) and top three antibiotic groups were the third-generation cephalosporins (n = 37, 25%), penicillins with extended spectrum (n = 31, 21%) and the second-generation cephalosporins (n = 21, 14%). Top three antibiotics for pediatric patients were ceftriaxone and cefuroxime both (n = 21, 14%) and amoxicillin (n = 20, 13%). These results show that in all PPS the third-generation cephalosporins were among the mostly used antibiotic groups for pediatric patients and ceftriaxone was among top three antibiotics in this patient group. The use of the third-generation cephalosporins can lead to the increase of resistant bacterial strains and should be reduced as a result [17, 18] . Some European countries have reported high increase of the third-generation cephalosporin-resistant Escherichia coli in their hospital wards [19] . At the same time some countries such as UK have succeeded in decreasing of the use of the third-generation cephalosporins with both publications from the Department of Health recommending good antimicrobial stewardship, e.g., the ''Start Smart then Focus'' approach [20] and a policy of restricting cephalosporin prescription and this approach helped to decrease the use of cephalosporins, for example, in the Children Hospital in Birmingham [21] . Currently there are almost no local and also national recommendations for antibiotic use in hospitals except one University Hospital with a maternity ward that has local recommendations for adults and the University Childrens' Hospital that has local recommendations for bronchiolitis, epiglottitis, croup and community acquired pneumonia treatment. This situation indicates an urgent need for recommendations both on national and local (hospital) level. Another problematic area is the high use of intravenous antibiotics. A total of 143 pediatric patients (86%) received intravenous antibiotics, and 91 (64%), for more than 48 h; 107 patients (85%) received antibiotics intravenously in May 2012 and 112 patients (74%) in November 2011. In this study, we did not evaluate the appropriateness of the route of therapy or the initial diagnosis. One explanation of such high use of intravenous antibiotics could be due to social acceptance that intravenous antibiotics are ''stronger'' than oral antibiotics in treating an infection during hospital stay. Some antibiotics (e.g., aminoglycosides) are not available in oral form although sometimes have off-label oral use [22] . Alternatively, some oral antibiotics are not available on the Latvian market, e.g., flucloxacillin and penicillin Whilst some infections (e.g., central nervous system infections) or patients groups (e.g., neonates) require parenteral use there are other patient groups (e.g., children, adolescent) and/or diagnoses where the disproportionately high use of intravenous antibiotics should be reduced at hospitals in Latvia. In some situations (e.g., community acquired pneumonia or some cases of acute pyelonephritis), switch to oral antibiotics allow reducing the stay at the hospital and has potential benefits because can decrease the risk of needle-borne infections, need for referral or admission, administration costs, and family-related costs [23] [24] [25] . Our results are similar with the study done in pediatric antimicrobial prescribing in 32 hospitals of 21 European countries where parenteral route was more commonly used than the oral route for both prophylactic and therapeutic indications [12] .
Antibiotic prophylaxis for surgical patients was not focused on this study. However, further analysis would be beneficial in the choice of agents, if prophylaxis is appropriately prescribed and especially duration of treatment. Surgical prophylaxis in general and unnecessary prolonged prophylaxis (>1 day) in particular are areas were serious improvements are needed. Although there were a small number of patients receiving a surgical prophylaxis in our study, the tendency was that the duration of the surgical prophylaxis appeared to be longer than recommended in a high proportion of the cases: 11 patients of 13 received prophylaxis longer than one day. These findings are similar with results of other studies [12, [26] [27] [28] . Some of studies show that many children may not receive antibiotics were proven benefit and could receive antibiotics when there is no clear indication for it [29] . The appropriate use of antibiotics could lead to essential saving not only for the hospital and patient but also for the health care system [30] and can help to decrease the incidence of the surgical site infection and hospital related costs. At the same time overuse of antibiotics can lead to the emergence or resistant microorganisms [13] .
The strength of this study is that all hospitals in Latvia used the same standardized protocol that was also used in hospitals in other countries and was tested in two ARPEC pilot studies in 2011 and also in two local pilot studies in four hospitals in Latvia in November 2011 and in May 2012. One common method used in all those studies allows comparing data not only at the country level, but also among the institutions from different countries. PPS are not expensive, but at the same time efficient method that allows to identify antibiotic prescribing trends and areas for improvement. Such a methodology was chosen as a study design for the ARPEC study of antibiotic prescribing analysis in pediatric and neonatal patients (both authors of this article participated in this ARPEC pilot study) [13] . There are PPS conducted in hospitals in Latvia focusing on adult patient [11] , but for the first time a PPS was conducted only in so many pediatric and neonatal wards and analyzed separately from adult patients.
Limitations of this study are associated with the study design -a cross sectional design allows capturing only particular numbers of patients. We have to analyze all results bearing in mind that they may represent only situation in the particular time period and patients with individual conditions [13] . In some hospitals only few patients received antimicrobial treatment. This was a reason why hospitals' results were not compared, but only general tendencies were analyzed. Nevertheless, these results are important because children are not small adults and we need more information about the use m e d i c i n a 5 0 ( 2 0 1 4 ) 1 7 5 -1 8 1 of medications, e.g., antibiotics in pediatric population in order to provide better care for them. Participation in the survey was voluntary and none of participants was paid for it. Invitations were sent to all hospitals in Latvia with pediatric and/or neonatal wards. Some hospitals did not respond to several invitation letters or declined participation. It is the main reason why this study does not contain information, for example, about tuberculosis treatment in pediatric population: tuberculosis is treated in a specialized clinic in one of the adult University hospitals which also has a pediatric ward. At the same time the University Children's Hospital participated in the survey and those specialists from hospitals who participated were very motivated and interested in the survey and its results. The PPS as a surveillance tool is the first step in auditing the antimicrobial use in hospitals and allows identification of priorities for quality improvement what was the main aim of this study.
Conclusions
We identified few problematic areas, which need improvement: the high use of third-generation cephalosporins for pediatric patients, prolonged surgical prophylaxis, predominant use of parenteral antibiotics and an urgent need for local antibiotic guidelines.
